EnteroBiotix Raises over $21m in Series A Financing to Advance its Microbiome Drug Pipeline
EnteroBiotix, a biopharmaceutical company developing novel high-diversity microbial therapeutics that enhance the gut microbiome and target multiple indications has closed an oversubscribed USD $21.5 million (UK £15.5m) Series A financing round. The proceeds will be used to further advance the […]